Strategies
AVAX Hyperliquid Trend-Pullback Continuation — Long-Short, Enter 4H Pullback Resumptions in the Direction of the Daily Trend, ATR Trailing Exit (Volatility-Scaled, 3-Parameter)
Outcome: Abandoned
AvaxHyperliquidTrendPullbackContinuationLS
Outcome Summary
AvaxHyperliquidTrendPullbackContinuationLS varied the entry mechanism — buying pullback resumptions in the direction of the daily trend rather than chasing crosses or breakouts — while staying in the factory's one surviving directional family, on high-beta AVAX and the under-weight Hyperliquid venue. It produced one of the better shapes of its cohort: +62.1%, PF 1.57, 1.69% per trade, a 13.5% drawdown, decorrelated alpha, a positive information ratio, and a distributed (non-outlier) return positive in 2024 and 2025. But the edge was not statistically established — Sharpe 0.51 with a confidence interval straddling zero over only ~2.5 years of single-regime, thin Hyperliquid history, with 2026 already softening. The analyst abandoned it at backtest review for the same reasons as its just-abandoned LINK-HL and ETH-HL siblings, judging optimization could not clear deflated Sharpe; it never reached optimization, analysis, or risk review.
Hypothesis
Implementation
Long-short, single-leg trend-PULLBACK CONTINUATION strategy on AVAXUSD.HYPERLIQUID perpetual, 4H primary bars with a 1-DAY trend filter. The daily leg (read via on_extra_bar) sets the permitted direction: sign of the 20-day daily return. On 4H bars the strategy measures how far price has retraced against that trend from the prior 20-bar swing extreme, in ATR units -- calculate_signal returns daily_dir * retrace_depth (continuous, volatility-scaled, ~0 at the extreme, growing through the pullback). It ARMS when the retrace reaches 1.5 x ATR and then enters only on RESUMPTION in the trend direction: a close above the previous bar's high in an uptrend, below the previous bar's low in a downtrend. A retrace deeper than 3x the arming depth disarms the setup (trend broken -- no entry). Exits on a 3x-ATR trailing stop from the best close since entry, or on the daily trend flipping against the position. Sizing risks ~1.5% of equity at the trailing-stop distance (qty = equity*0.015/(3*ATR)), capped at 25% of equity x 2x leverage.
Verification Results
Real capacity/impact limit: impact_cost_pct 20.92%, capacity_usd ~$2.29M on thin AVAX-HL. The +15.37% already absorbs the ~21% impact drag (folded); doesn't scale. Small-book — risk-officer call, not a code bug.
Pure-OHLCV trend book, 68 trades, Sharpe CI straddles zero — but return_kurtosis 4.15 and top-3 trades ~14% of profit, so the broad-based/non-outlier-carried claim holds. Novel pullback entry; needs walk-forward OOS confirmation.
Backtest Review
- Sharpe
- 0.51
- Total return
- 62.05%
- Max drawdown
- 13.50%
- Trades
- 159
- Win rate
- 52.2%
- Profit factor
- 1.57
Distributed edge, not an outlier mirage: return_kurtosis 6.57, skew 0.36; positive years (2024 +11.5%, 2025 +42.4%), max_drawdown 13.5%, PF 1.57, decorrelated alpha 0.14, IR 0.51, 159 trades
Novel pullback-resumption entry; correct daily-leg wiring
Edge not significant: Sharpe 0.51 with CI [-0.57, 1.54] straddling zero deeply, over a short ~2.5-year single-regime window (AVAX-HL 4H from 2024-02)
Thin-market drag: impact_cost_pct 12.8%, capacity only ~$6.1M
Recent regime weakening: 2026 +0.7% flat with negative Apr/May/Jul/Aug months and rolling_sharpe going negative in mid-2026
Hyperliquid directional trend is the 0/97 class (L41); near-identical LINK-HL (Sharpe 0.46, CI-low -0.60) and ETH-HL Donchian just abandoned for the same profile
Outcome Summary
A novel, well-shaped pullback-continuation entry with distributed returns and a positive information ratio still cannot be promoted when its Sharpe CI straddles zero over a short single-regime, thin-liquidity sample — the recurring Hyperliquid lesson is that a promising directional profile needs multi-regime depth and capacity the venue's ~2.5-year history cannot supply.
The analyst abandoned it at backtest review with the same verdict as its Hyperliquid directional siblings: a good distributed shape but a statistically unestablished edge — Sharpe 0.51 with a CI straddling zero over a short ~2.5-year single-regime (all-bullish) window, thin market (impact partly a small-scale artifact), softening recent regime where the OOS/holdout windows sit, and membership in the 0/97-survival Hyperliquid directional-trend class. Best-of-N over ~225 optimization trials on that base would not clear deflated Sharpe.
A long-short, single-instrument trend-continuation strategy on AVAXUSD.HYPERLIQUID (4H primary + 1D trend filter, 3 parameters) that waited for a pullback against the established daily trend and entered only when the 4H price resumed in the trend direction (buying the resumption, never fading), exiting on an ATR trailing stop or a daily-trend flip — a distinct pullback entry within the factory's surviving directional-trend family.
The backtest (AVAXUSD.HYPERLIQUID 4H, 911 data days from 2024-02) returned +62.1% over 159 balanced trades (82L/77S) with profit factor 1.57, avg_trade_return_pct 1.69%, a 13.5% max drawdown, decorrelated alpha 0.14, information ratio 0.51, and a genuinely distributed edge (kurtosis 6.57, skew 0.36, positive years 2024 +11.5%, 2025 +42.4%). But Sharpe was only 0.51 with a CI [-0.57, 1.54] straddling zero deeply, impact cost was 12.8% of gross PnL, capacity was thin (~$6.1M), and 2026 was flat with a negative mid-year rolling Sharpe.
Backtest and paper results are hypothetical. Trading involves risk of loss.